Bortezomib-Based Therapy Effective for Relapsed/Refractory Myeloma

Relapsed or refractory multiple myeloma patients experience high response rates, overall survival with bortezomib-based therapy.

Source: CancerNetwork - August 13, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news